Antiplatelet drugs are used to prevent the formation of blood clots in patients with conditions such as heart disease, stroke and peripheral arterial disease. Additionally, antiplatelet drugs help prevent platelet aggregation and reduce the risk of blood clots. Antiplatelet medicines are prescribed after certain surgical procedures and to patients at high risk for heart attacks, strokes or blood clots. The global antiplatelet drugs market is gaining widespread acceptance as these medications play a key role in preventing diseases like atherosclerosis and myocardial infarction.

The global antiplatelet drugs market is estimated to be valued at US$ 2321.37 million in 2023 and is expected to exhibit a CAGR of 0.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The rising aging population is one of the key factors expected to fuel the growth of Global Antiplatelet Drugs Market Size during the forecast period. According to the United Nations, the number of people aged 60 or above is expected to more than double by 2050 and reach around 2 billion from the current 900 million globally. With age, risks of cardiovascular and neurological diseases increases significantly. Older individuals are more prone to conditions requiring antiplatelet drugs such as heart attacks, strokes, peripheral vascular diseases and thrombotic events. Therefore, the surging geriatric population susceptible to such illnesses and disorders will upsurge the demand for antiplatelet medications for prevention and treatment, thereby augmenting the market growth over the forecast timeframe.

Porter’s Analysis

Threat of new entrants: Low barrier to entry due to easy availability of raw materials but established brands enjoy customer loyalty and economies of scale.

Bargaining power of buyers: Buyers have high bargaining power due to availability of substitutes and no product differentiation. They can negotiate on price.

Bargaining power of suppliers: Suppliers have moderate power due to availability of alternative raw material sources but suppliers of key ingredients have some power.

Threat of new substitutes: Substitutes like anticoagulants pose threat but limited use due to side effects.

Competitive rivalry: High due to many established brands and private labels competing on pricing and marketing.

SWOT Analysis

Strengths: Established brands, wide acceptance, effective treatment.

Weaknesses: High cost, side effects risk, requires lifelong usage.

Opportunities: Growth in emerging markets, increase in cardiac cases, new product innovations.

Threats: Patent expiries, regulatory challenges, substitutes development.

Get More Insights On This Topic: http://medicalinfoblogs.weebly.com/blog/incorporating-antiplatelet-drugs-market-is-estimated-to-witness-moderate-growth-owing-to-increase-in-aging-population